Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	18 fdg	-	-	-	-	1件: 145 💬
2	Acetate	Acetate	-	-	-	43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
3	Acth	Corticotropin	1件: D00146 💬	1件: MC2R 💬	5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	5件: 13, 66, 145, 193, 222 💬
4	Adrenocorticotropin hormone	-	-	-	-	1件: 145 💬
5	Cannabidiol	Cannabidiol	1件: D10915 💬	2件: CNR1, CNR2 💬	4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis	17件:  6 ,  8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬
6	Cannabidiol (cbd)	Cannabidiol	1件: D10915 💬	2件: CNR1, CNR2 💬	4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis	6件:  6 , 140, 144, 145, 156, 158 💬
7	Cannabidiol oral solution	Cannabidiol	1件: D10915 💬	2件: CNR1, CNR2 💬	4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis	4件: 140, 144, 145, 193 💬
8	Cbd	-	-	-	-	11件:  2 ,  6 ,  8 , 13, 46, 140, 144, 145, 156, 158, 206 💬
9	Combination therapy with vigabatrin and prednisolone	Prednisolone	9件: D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	2件: ABAT, NR3C1 💬	8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件: 145 💬
10	Cosyntropin	Tetracosactide	1件: D00284 💬	1件: MC2R 💬	5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	3件: 83, 113, 145 💬
11	Cosyntropin injectable suspension 1 mg/ml + vigabatrin	Tetracosactide	2件: D00284, D00535 💬	2件: ABAT, MC2R 💬	12件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway	1件: 145 💬
12	Cosyntropin injectable suspension, 1 mg/ml	Tetracosactide	1件: D00284 💬	1件: MC2R 💬	5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	1件: 145 💬
13	Decortin h	-	-	-	-	3件: 66, 97, 145 💬
14	Fenfluramine	Fenfluramine	1件: D07945 💬	4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬	6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	3件: 140, 144, 145 💬
15	Ganaxolone	Ganaxolone	1件: D04300 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	4件: 145, 152, 158, 206 💬
16	Gwp42003-p	-	-	-	-	5件: 140, 144, 145, 156, 158 💬
17	Intravenous methylprednisolone	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 13, 145 💬
18	Jbpos0101	JBPOS0101	-	-	-	1件: 145 💬
19	M071754	-	-	-	-	1件: 145 💬
20	Melatonin	Melatonin	1件: D08170 💬	2件: MTNR1A, MTNR1B 💬	2件: Circadian entrainment, Neuroactive ligand-receptor interaction	11件:  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
21	Methylprednisolone	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
22	Modified atkins diet	-	-	-	-	2件: 145, 157 💬
23	Null	-	-	-	-	16件:  6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
24	Oral pednisolone	-	-	-	-	1件: 145 💬
25	Oral prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 49, 145 💬
26	Other: modified atkins diet	-	-	-	-	1件: 145 💬
27	Prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
28	Pyridoxine	Pyridoxine	2件: D02179, D08454 💬	-	-	2件: 93, 145 💬
29	Pyridoxine plus prednisolone	Prednisolone	10件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 145 💬
30	Radiprodil	Radiprodil	-	-	-	1件: 145 💬
31	Sabril	-	-	-	-	1件: 145 💬
32	Sabril granules for oral use	-	-	-	-	1件: 145 💬
33	Sabril sachets	-	-	-	-	1件: 145 💬
34	Sabrilex	-	-	-	-	1件: 145 💬
35	Sabril®	-	-	-	-	1件: 145 💬
36	Soluble prednisolone tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 145 💬
37	Spt3162	-	-	-	-	1件: 145 💬
38	Synacthen depot	-	-	-	-	3件: 83, 145, 222 💬
39	Tetracosactide	Tetracosactide	1件: D00284 💬	1件: MC2R 💬	5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	4件: 83, 113, 145, 222 💬
40	Tetracosactide acetate	Acetate	1件: D00284 💬	1件: MC2R 💬	5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	2件: 83, 145 💬
41	Ucb3491	-	-	-	-	1件: 145 💬
42	Vgb-st	-	-	-	-	1件: 145 💬
43	Vgb-st soluble tablets	-	-	-	-	1件: 145 💬
44	Vigabatrin	Vigabatrin	1件: D00535 💬	1件: ABAT 💬	7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	2件: 145, 158 💬
45	Vigabatrin tablets	Vigabatrin	1件: D00535 💬	1件: ABAT 💬	7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件: 145 💬
46	Vigabatrin: vigabatrin new st formulation then sabril®	Vigabatrin	1件: D00535 💬	1件: ABAT 💬	7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件: 145 💬

先頭へ